Follow Up Study to Evaluate the Pharmacotherapy of Covid-19 Patients in The Tertiary Care Hospital
Not Applicable
Completed
- Conditions
- Health Condition 1: J80- Acute respiratory distress syndromeHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/08/035756
- Lead Sponsor
- Adichunchanagiri University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 673
Inclusion Criteria
Diagnosed with Covid-19 by any diagnostic tool (i.e., RT-PCR, CT scan or X-Ray and any other as per the clinical decision taken by the treating physician).
Exclusion Criteria
Those who does not meet inclusion criteria.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study can help in rationalization, individualization of drug therapy. <br/ ><br> The study minimizes the chance of treatment failure and drug related complications. <br/ ><br> The study can suggest the alternative drugs during drug shortage. <br/ ><br> This study can prevent the possible drug-drug interaction. <br/ ><br>Timepoint: <br/ ><br>3 years
- Secondary Outcome Measures
Name Time Method The study can suggest the alternative drugs during drug shortage. <br/ ><br> This study can prevent the possible drug-drug interaction.Timepoint: immediately